Longfian is thrilled to announce a major milestone - 800,000 oxygen concentrators and therapy devices sold across more than 120 countries worldwide. This achievement reflects the trust that healthcare providers and patients have placed in our products.
Milestone Breakdown:
- Medical oxygen concentrators: 520,000 units
- Portable oxygen solutions: 180,000 units
- Veterinary oxygen systems: 60,000 units
- Hyperbaric chambers: 25,000 units
- EWOT systems: 15,000 units
Key Markets:
- North America: 180,000 units
- Europe: 160,000 units
- Asia-Pacific: 220,000 units
- Middle East & Africa: 140,000 units
- Latin America: 100,000 units
This milestone is a testament to our commitment to quality, innovation, and customer service. Each device represents improved quality of life for patients suffering from respiratory conditions, athletes seeking performance enhancement, and animals requiring veterinary care.
Looking ahead, Longfian is investing heavily in R&D to develop the next generation of smart oxygen therapy devices with IoT connectivity, AI-powered diagnostics, and personalized treatment protocols. Our goal is to reach 1 million units sold by 2025 while maintaining the highest standards of quality and reliability.
We extend our heartfelt gratitude to our customers, distributors, and employees who have made this achievement possible.